vs

Side-by-side financial comparison of HARTE HANKS INC (HHS) and Medirom Healthcare Technologies Inc. (MRM). Click either name above to swap in a different company.

HARTE HANKS INC is the larger business by last-quarter revenue ($39.9M vs $21.1M, roughly 1.9× Medirom Healthcare Technologies Inc.). HARTE HANKS INC runs the higher net margin — 5.5% vs -21.3%, a 26.8% gap on every dollar of revenue. Medirom Healthcare Technologies Inc. produced more free cash flow last quarter ($-2.4K vs $-686.0K).

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.

HHS vs MRM — Head-to-Head

Bigger by revenue
HHS
HHS
1.9× larger
HHS
$39.9M
$21.1M
MRM
Higher net margin
HHS
HHS
26.8% more per $
HHS
5.5%
-21.3%
MRM
More free cash flow
MRM
MRM
$683.6K more FCF
MRM
$-2.4K
$-686.0K
HHS

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
HHS
HHS
MRM
MRM
Revenue
$39.9M
$21.1M
Net Profit
$2.2M
$-4.5M
Gross Margin
10.8%
Operating Margin
-0.3%
-28.5%
Net Margin
5.5%
-21.3%
Revenue YoY
-15.4%
Net Profit YoY
EPS (diluted)
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HHS
HHS
MRM
MRM
Q4 25
$39.9M
Q3 25
$39.5M
Q2 25
$38.6M
$21.1M
Q1 25
$41.6M
Q4 24
$47.1M
Q3 24
$47.6M
Q2 24
$45.0M
Q1 24
$45.4M
Net Profit
HHS
HHS
MRM
MRM
Q4 25
$2.2M
Q3 25
$-2.3M
Q2 25
$-335.0K
$-4.5M
Q1 25
$-392.0K
Q4 24
Q3 24
$142.0K
Q2 24
$-27.8M
Q1 24
$-171.0K
Gross Margin
HHS
HHS
MRM
MRM
Q4 25
Q3 25
Q2 25
10.8%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
HHS
HHS
MRM
MRM
Q4 25
-0.3%
Q3 25
1.3%
Q2 25
0.1%
-28.5%
Q1 25
-0.1%
Q4 24
-3.3%
Q3 24
4.0%
Q2 24
3.0%
Q1 24
0.8%
Net Margin
HHS
HHS
MRM
MRM
Q4 25
5.5%
Q3 25
-5.8%
Q2 25
-0.9%
-21.3%
Q1 25
-0.9%
Q4 24
Q3 24
0.3%
Q2 24
-61.8%
Q1 24
-0.4%
EPS (diluted)
HHS
HHS
MRM
MRM
Q4 25
$0.30
Q3 25
$-0.31
Q2 25
$-0.05
Q1 25
$-0.05
Q4 24
$-0.31
Q3 24
$0.02
Q2 24
$-3.84
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HHS
HHS
MRM
MRM
Cash + ST InvestmentsLiquidity on hand
$5.6M
$252.3K
Total DebtLower is stronger
$8.8M
Stockholders' EquityBook value
$20.5M
$1.6M
Total Assets
$91.8M
$52.0M
Debt / EquityLower = less leverage
5.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HHS
HHS
MRM
MRM
Q4 25
$5.6M
Q3 25
$6.5M
Q2 25
$4.8M
$252.3K
Q1 25
$9.0M
Q4 24
$9.8M
Q3 24
$5.9M
Q2 24
$11.0M
Q1 24
$11.5M
Total Debt
HHS
HHS
MRM
MRM
Q4 25
Q3 25
Q2 25
$8.8M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
HHS
HHS
MRM
MRM
Q4 25
$20.5M
Q3 25
$19.9M
Q2 25
$22.2M
$1.6M
Q1 25
$21.4M
Q4 24
$21.7M
Q3 24
$21.0M
Q2 24
$20.6M
Q1 24
$20.0M
Total Assets
HHS
HHS
MRM
MRM
Q4 25
$91.8M
Q3 25
$92.7M
Q2 25
$95.0M
$52.0M
Q1 25
$100.6M
Q4 24
$101.8M
Q3 24
$108.1M
Q2 24
$109.7M
Q1 24
$113.4M
Debt / Equity
HHS
HHS
MRM
MRM
Q4 25
Q3 25
Q2 25
5.55×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HHS
HHS
MRM
MRM
Operating Cash FlowLast quarter
$737.0K
$-2.3K
Free Cash FlowOCF − Capex
$-686.0K
$-2.4K
FCF MarginFCF / Revenue
-1.7%
-0.0%
Capex IntensityCapex / Revenue
3.6%
0.0%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HHS
HHS
MRM
MRM
Q4 25
$737.0K
Q3 25
$3.2M
Q2 25
$-4.8M
$-2.3K
Q1 25
$-818.0K
Q4 24
$4.0M
Q3 24
$-2.9M
Q2 24
$1.6M
Q1 24
$-5.7M
Free Cash Flow
HHS
HHS
MRM
MRM
Q4 25
$-686.0K
Q3 25
$2.2M
Q2 25
$-5.1M
$-2.4K
Q1 25
$-923.0K
Q4 24
$3.4M
Q3 24
$-4.9M
Q2 24
$926.0K
Q1 24
$-6.2M
FCF Margin
HHS
HHS
MRM
MRM
Q4 25
-1.7%
Q3 25
5.5%
Q2 25
-13.1%
-0.0%
Q1 25
-2.2%
Q4 24
7.3%
Q3 24
-10.2%
Q2 24
2.1%
Q1 24
-13.7%
Capex Intensity
HHS
HHS
MRM
MRM
Q4 25
3.6%
Q3 25
2.5%
Q2 25
0.6%
0.0%
Q1 25
0.3%
Q4 24
1.3%
Q3 24
4.0%
Q2 24
1.5%
Q1 24
1.2%
Cash Conversion
HHS
HHS
MRM
MRM
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-20.76×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

MRM
MRM

Professional services expense$20.0M95%
Other$1.1M5%

Related Comparisons